康圣环球(09960)：武汉康圣达拟1239.6万元收购华西康圣达40%股权

智通财经网2025-11-25

智通财经APP讯，康圣环球(09960)发布公告，武汉康圣达(一家中国综合实体)透过北交所公开挂牌程序成功竞得华西健康科技持有的华西康圣达(一家中国综合实体)40%股权。于2025年11月25日，武汉康圣达与华西健康科技订立产权交易合同，武汉康圣达同意收购，而华西健康科技同意出售华西康圣达40%股权，对价为人民币 1239.6万元。于本交易完成后，华西康圣达将成为本公司间接全资附属公司。经董事会...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2586473749?lang=zh_CN&edition=full","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_3.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","is_english":false,"pubTime":"2025-11-25 21:02","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2586473749","market":"fut","top_or_hot":-1,"title":"康圣环球(09960)：武汉康圣达拟1239.6万元收购华西康圣达40%股权","media":"智通财经网","content":"<div>\n<p>智通财经APP讯，康圣环球(09960)发布公告，武汉康圣达(一家中国综合实体)透过北交所公开挂牌程序成功竞得华西健康科技持有的华西康圣达(一家中国综合实体)40%股权。于2025年11月25日，武汉康圣达与华西健康科技订立产权交易合同，武汉康圣达同意收购，而华西健康科技同意出售华西康圣达40%股权，对价为人民币  1239.6万元。于本交易完成后，华西康圣达将成为本公司间接全资附属公司。经董事会...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1373540.html\">网页链接</a>\n\n</div>\n","source":"highlight_zhitongcaijin","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康圣环球(09960)：武汉康圣达拟1239.6万元收购华西康圣达40%股权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康圣环球(09960)：武汉康圣达拟1239.6万元收购华西康圣达40%股权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-25 21:02 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1373540.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，康圣环球(09960)发布公告，武汉康圣达(一家中国综合实体)透过北交所公开挂牌程序成功竞得华西健康科技持有的华西康圣达(一家中国综合实体)40%股权。于2025年11月25日，武汉康圣达与华西健康科技订立产权交易合同，武汉康圣达同意收购，而华西健康科技同意出售华西康圣达40%股权，对价为人民币  1239.6万元。于本交易完成后，华西康圣达将成为本公司间接全资附属公司。经董事会...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1373540.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1219","symbol_name":"保健护理服务","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1373540.html","article_id":"2586473749","we_media_id":null,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_3.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2586473749","pubTimestamp":1764075772,"columns":[],"sourceInfo":{"source_id":"highlight_zhitongcaijin","name":"智通财经网"},"weMediaInfo":null,"summary":"康圣环球(09960)发布公告，武汉康圣达(一家中国综合实体)透过北交所公开挂牌程...","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1219":"保健护理服务","BK1587":"次新股","09960":"康圣环球"},"translate_title":"Kangsheng Global (09960): Wuhan Kangshengda plans to acquire 40% equity of West China Kangshengda for 12.396 million yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09960":1.5},"content_text":"智通财经APP讯，康圣环球(09960)发布公告，武汉康圣达(一家中国综合实体)透过北交所公开挂牌程序成功竞得华西健康科技持有的华西康圣达(一家中国综合实体)40%股权。于2025年11月25日，武汉康圣达与华西健康科技订立产权交易合同，武汉康圣达同意收购，而华西健康科技同意出售华西康圣达40%股权，对价为人民币  1239.6万元。于本交易完成后，华西康圣达将成为本公司间接全资附属公司。经董事会审慎评估，董事会认为本交易符合本公司及股东的整体利益，具体而言：(一)华西康圣达作为本集团“全国特检网络+区域中心实验室”战略在西南地区的核心平台，已发展成为覆盖四川、重庆、云南及贵州的区域性高端特检服务提供商，在肿瘤早筛、分子诊断等领域具备规模化检测能力与成熟经验。本次实现全资控股将有助于本集团加强对华西康圣达业务运营及战略方向的统筹管理，确保本集团整体战略在西南地区高效、一致地执行;(二)作为具备领先优势的第三方医学检验(ICL) 平台，华西康圣达将有力支撑本集团“ICL + IVD”双轨发展战略，切实推动“以  ICL驱动IVD产品开发，以IVD反哺ICL服务升级”的协同效应;(三)本公司将全面主导华西康圣达的管理层任命、绩效考核及资源配置，进一步提升跨区域项目(如区域检验中心共建、基层医疗机构合作等)的执行效率。本公司亦将进一步延续和深化与四川大学华西医院的临床与科研合作，并在此基础上更好地整合西南地区的渠道、技术与医疗资源，强化区域一体化运营能力。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2586473749","isCrawlerRequest":true}